×
About 5,395 results

ALLMedicine™ Angina Pectoris Center

Research & Reviews  1,251 results

Plasma Leukocyte Cell-Derived Chemotaxin 2 (LECT2) as a Risk Factor of Coronary Artery ...
https://doi.org/10.1177/00033197211028023
Angiology Wei M, Liu J et. al.

Jul 29th, 2021 - Many studies have shown that leukocyte cell-derived chemotaxin 2 (LECT2) is associated with metabolic disorders, which is a risk factor of arteriosclerosis. We assessed the level of LECT-2 in patients with coronary artery disease (CAD) and its sev...

Aging Induced Impairment of Vascular Function - Mitochondrial Redox Contributions and P...
https://doi.org/10.1089/ars.2021.0031
Antioxidants & Redox Signaling; Tracy EP, Hughes W et. al.

Jul 28th, 2021 - The vasculature responds to the respiratory needs of tissue by modulating luminal diameter through smooth muscle constriction or relaxation. Coronary perfusion, diastolic function, and coronary flow reserve are drastically reduced with aging. This...

Relation of the Number of Cardiovascular Conditions and Short-term Symptom Improvement ...
https://doi.org/10.1016/j.amjcard.2021.06.007
The American Journal of Cardiology; Flynn CR, Orkaby AR et. al.

Jul 21st, 2021 - With aging of the population, cardiovascular conditions (CC) are increasingly common in individuals undergoing PCI for stable angina pectoris (AP). It is unknown if the overall burden of CCs associates with diminished symptom improvement after PCI...

Medical management of anginal symptoms in women with stable angina pectoris: A systemat...
https://doi.org/10.1016/j.ijcard.2021.07.018
International Journal of Cardiology; Webb CM, Collins P

Jul 18th, 2021 - Medical therapies are used to improve stable anginal symptoms and quality of life in clinical practice however the evidence for the use of antianginal medication in women is largely unknown. We conducted a systematic review to investigate the exte...

Scavenger Receptor BI Induced by HDL From Coronary Heart Disease May Be Related to Athe...
https://doi.org/10.1177/10760296211029710
Clinical and Applied Thrombosis/hemostasis : Official Jou... Gao F, Feng GJ et. al.

Jul 14th, 2021 - This study aims to determine whether dysfunctional High Density Lipoprotein (HDL) influenced the expression of scavenger receptor class B type Ⅰ (SR-B1) to determine reverse cholesterol transport. Blood samples obtained from coronary heart disease...

see more →

Guidelines  2 results

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood...
https://doi.org/10.1016/j.cjca.2016.02.066
The Canadian Journal of Cardiology; Leung AA, Nerenberg K et. al.

Apr 28th, 2016 - Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 ne...

Recommendations for advancing the care of Canadians living with refractory angina pecto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723022
The Canadian Journal of Cardiology; McGillion M, L'Allier PL et. al.

Jul 9th, 2009 - Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.|2009|McGillion M,L'Allier PL,Arthur H,Watt-Watson J,Svorkdal N,|epidemiology,therapy,epidemiology,

see more →

Drugs  740 results see all →

Clinicaltrials.gov  86 results

Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Japan Study
https://clinicaltrials.gov/ct2/show/NCT03729739

Apr 28th, 2020 - Patients at high risk of having one or more coronary stenosis are evaluated routinely by invasive coronary angiography (CAG). Lesions are often quantified by visual assessment of the angiogram, but physiological assessment of the functional signif...

Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
https://clinicaltrials.gov/ct2/show/NCT02548611

Feb 25th, 2020 - Patients with stable or clinically unstable (biomarker-negative) angina pectoris who are in need of coronary intervention will be randomly assigned in one of the treatment strategies - 60 mg of prasugrel or 600 mg clopidogrel just prior to percuta...

Virtual 360°-Tour in Coronary Computed Tomography
https://clinicaltrials.gov/ct2/show/NCT03677791

Jan 22nd, 2020 - The purpose of the study is to evaluate the effectiveness of the virtual 360° counselling environment in the anxiety and adherence to treatment of the patients coming to CCTA (coronary computed tomography angiography). The virtual, 360° environmen...

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal...
https://clinicaltrials.gov/ct2/show/NCT03666832

Dec 30th, 2019 - Inclusion Subjects who are males or females ≥ 19 years of age Subjects who have the following history of first-line gemcitabine and nab-paclitaxel among patients with cytologically or histologically proven metastatic pancreatic ductal adenocarcino...

Investigating the Role of Active Versus Chronic Coronary Artery Calcification on Acute Myocardial Infarct
https://clinicaltrials.gov/ct2/show/NCT03712020

Jun 7th, 2019 - Contemporary techniques used to visualize coronary artery calcification include standard non-contrast computed tomography (CT) of the coronaries measuring amount of calcium deposition in the coronaries, contrast CT and more recently, using sodium-...

see more →

News  76 results

Advisory Panel Balks at Neovasc Reducer for Refractory Angina
https://www.medscape.com/viewarticle/939965

Oct 28th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...

Advisory Panel Balks at Neovasc Reducer for Refractory Angina
https://www.staging.medscape.com/viewarticle/939965

Oct 28th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...

No Mortality Signal With Paclitaxel Balloons in Coronary PCI
https://www.medscape.com/viewarticle/926369

Mar 6th, 2020 - Paclitaxel drug-coated balloons (DCB) are not associated with increased mortality, compared with non-DCB devices, and may even confer additional survival benefits when used in coronary revascularization, a new meta-analysis shows. Investigators an...

Fast Five Quiz: Coronary Artery Atherosclerosis
https://reference.medscape.com/viewarticle/920857_3

Nov 11th, 2019 - Answer 2/5 Which of the following is most accurate regarding the presentation and physical examination of patients with coronary artery atherosclerosis? Your peers chose: High or low blood pressure may be noted in patients with atherosclerosis, an...

Cognitive Decline May Accelerate After Ischemic Events
https://www.medscape.com/viewarticle/914656

Jun 19th, 2019 - After a diagnosis of myocardial infarction (MI) or angina pectoris, individuals enrolled in the English Longitudinal Study of Aging (ELSA) showed more accelerated cognitive decline than those who remained free of coronary heart disease (CHD). The ...

see more →

Patient Education  3 results see all →